KLRA - Company ID 0002096997
The table below shows Kailera Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 |
|---|---|
| Cash & equivalents | $111.83M |
| Short-term investments | $407.35M |
| Receivables | - |
| Inventory | - |
| Total current assets | $530.32M |
| Property, plant & equipment | $1.85M |
| Goodwill | - |
| Total assets | $624.76M |
| Accounts payable | $7.09M |
| Total current liabilities | $54.84M |
| Long-term debt | - |
| Total liabilities | $64.48M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$447.53M |
| Total equity | -$432.09M |